What's Hot
View all perspectives
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 2 months ago
#ACR21 #Abstr1457 Nine more well-phenotyped patients with VEXAS were presented. New info:
💠Peritubular capillaritis & cryo vasculitis
💠Most cs- & bDMARDs had limited efficacy
💠Potential therapy with plasma cell blockade & stem cell transplant
@RheumNow https://t.co/iDwJAdbf4M https://t.co/X4ENz4M91u
sheila RHEUMarampa
3 years 2 months ago
This post hoc analysis of SPIRIT 1&2 in #psoriaticarthritis pts w/ symptoms indicative of axial involvement showed that Ixekizumab reduced axial symptoms and improved QoL at wks 16 & 24.
Reassuring data.
@RheumNow #ACR21 abs1347 https://t.co/aFixZdiEyx
Dr. John Cush RheumNow
3 years 2 months ago
Risankizumab for Active Psoriatic Arthritis with Dr. Robert Chao ( @doctorRBC )
#ACR21
https://t.co/0zskkywWu1 https://t.co/n3qs19rQNG
Janet Pope Janetbirdope
3 years 2 months ago
Interesting results where cannabidiol NEG results in RCT in hand OA and PsA. ? Throw out the ‘pot’with the dish water? Did it stimulate appetites? Was pain the same but interference less? Abst#1456 #ACR21 @RheumNow https://t.co/rnz82Paxkr
David Liew drdavidliew
3 years 2 months ago
Interesting question came up: why would you change a RA patient from JAKi to JAKi?
The main reason I can think of would be if the first JAKi worked a bit (but not enough to continue, or AEs got in the way).
That would clearly favour to better survival
#ACR21 ABST1442 @RheumNow https://t.co/kDiJVbJfit
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 2 months ago
#ACR21 #Abstr1484 Hands down one of the most impressive results and trial design. RHAPSODY: Rilonacept led to ⬇️risk of pericarditis recurrence vs PBO (7% vs 74%; HR 0.04). Median time to resolution of pain and CRP were 5 & 7 Days. FDA approved @RheumNow https://t.co/Zty2WnkJEQ https://t.co/xGqt9Lwvjj
This report highlights the VITAL trial; the ORAL Surveillance Study; and the Microbiome study of monozygotic psoriasis patients.
PsA commonly affects peripheral joints. In up to a quarter of PsA patients, the spine may be involved and this is known as psoriatic spondylitis (PsSpA). An important research question is whether PsSpA and Axial Spondyloarthritis (AxSpA) with psoriasis are separate conditions or not.
Dr. John Cush RheumNow
3 years 2 months ago
RheumNow’s expanded coverage of the #ACR21 meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 2 months ago
Realised i have not been out of house apart from hospital visits 😳🙈#MeTime outdoor in the UK 🇬🇧 Falls season while enjoying #ACR21 talks by the New Masters @RheumNow #Rheumpix https://t.co/HYLKkECvCv
Effie Koliopoulos RisingAboveRa
3 years 2 months ago
Loved this session on: Preclinical Rheumatoid Arthritis- Can we stop RA? As a patient advocate living with RA, my providers have always ran tests on my microbiome. The findings have correlated with my disease flares, and was a big trigger overall. #ACR21 @ACRheum Thank you! https://t.co/6hm6hr85JS
Ashima Makol MD AshimaMakol
3 years 2 months ago
Erdheim Chester Disease
👉A histiocytic,myeloid malignancy
👉 “Coated Aorta” Classic peri-aortitis inv. Thoracic & Abdominal Aorta
👉 “Hairy Kidneys” on CT
👉 Abn PET-CT, foamy histiocytes on path
👉 Refer to onc for t/t
#ACR21 ✨Must See✨ session on Pearls by Dr. John Stone!! https://t.co/qobSsPxAhY
swethaann23 swethaann23
3 years 2 months ago
So humbled and honored
Thank you ACR /RRF for the constant support
#ACR21 https://t.co/SAE6ZfYmm5
Veena Katikineni VeenaRheumMD
3 years 2 months ago
Dr. Fujimoto provides a wonderful overview of skin findings in DM by antibody
#ACR21 #ACRAmbassador https://t.co/KpOsgKPU7j
Poster Hall